Ubie, a trailblazing AI-driven healthcare company, has achieved a new milestone with its AI Symptom Checker, surpassing 2 million uses in the U.S. in just over a year. Leveraging this expanding user engagement, Ubie is advancing its partnerships with pharmaceutical companies to promote early disease detection and treatment. Collaborations with industry giants like Takeda, Boehringer Ingelheim, and Pfizer exemplify Ubie's extensive efforts across a broad range of medical conditions, promoting improved patient care through cutting-edge digital health solutions.
NEW YORK, Dec. 5, 2023 /PRNewswire/ -- Ubie, a forerunner in the digital health arena, proudly announces a notable achievement that underscores its commitment to revolutionizing healthcare: Ubie's AI Symptom Checker has been used more than 2 million times in the U.S. since its introduction to the market just over a year ago. This milestone demonstrates the significant traction the tool has gained among individuals eager to better understand and manage their health.
Since Ubie's expansion into the U.S. market, the company has been focused on empowering individuals to recognize symptoms early and pursue timely healthcare discussions. This process provides users with in-depth insights into their symptoms, a comprehensive analysis of potential diseases, signs to look out for, and the ideal specialist to consult.
As an evidence-based AI company, data lies at the core of Ubie's operations and Ubie's unique relationship with its users allows the collection of differentiated quantitative and qualitative data. Based on user feedback, approximately 75% of patients plan to seek professional medical advice after checking their symptoms with Ubie, reflecting Ubie's ability to promote high-value care. U.S. user stories illustrate the benefits of Ubie's AI Symptom Checker:
Kota Kubo, CEO of Ubie, expresses his enthusiasm: "Surpassing 2 million uses in the U.S. in just a year is more than a number—it's a marker of our growing role in helping Americans promptly address health concerns and seek professional care. Our technology is designed to complement the work of healthcare providers, bridging the gap from initial concern to professional care."
Ubie's collaborations with leading pharmaceutical companies demonstrate the effectiveness of digital health in addressing various medical conditions:
Recent press releases reflect Ubie's commitment to enhancing the healthcare experience:
For more information about Ubie and its AI Symptom Checker, please visit Ubie AI Symptom Checker.
Contact:
Ryosei Hatakeyama
Ubie Inc.
1460 Broadway, New York, NY 10036
Email: pr@ubiehealth.com
Note to Editors: For more details or to arrange an interview with CEO Kota Kubo, please reach out to Ryosei Hatakeyama at the contact information above.